Table 1.
Application | Nanomaterial | Cargo | References |
---|---|---|---|
MRI | Iron oxide nanoparticles | N/A | Lee et al., 2012[49] Zhang et al., 2014[60] |
Fluorescence imaging | PEG-PCL polymeric nanoparticles | NIR dye (SiNc) | Moses et al., 2020[11] |
Photothermal therapy | Hollow gold nanospheres | N/A | Guo et al., 2017[43] |
PEG-PCL polymeric nanoparticles | NIR dye (SiNc) | Moses et al., 2020[11] | |
Gene Therapy | Lipid-chitosan micelles-DNA polyplex | Plasmid DNA | Zhao et al., 2012[45] |
PAMAM dendrimer-DNA polyplex | Plasmid DNA | Wang et al., 2014[104] | |
PEI–PEG–RGD-miRNA polyplex | miRNA | Liang et al., 2017[98] | |
PEI-chitosan oligosaccharide–siRNA polyplex | siRNA | Zhao et al., 2016[61] | |
Combinatorial therapy | PLGA polymeric nanoparticles | Curcumin & letrozole | Jana et al., 2014[100] |
Epigallocatechin gallate & doxycycline | Singh et al., 2015[101] | ||
Pain treatment | Lipid grafted chitosan micelles-coated nanostructured lipid carriers | P2X3 receptor antagonist (A317491) | Yuan et al., 2017[44] |
Antioxidant therapy | Cerium oxide nanoparticles | N/A | Chaudhury et al., 2012[99] |
Immunotherapy | Mesoporous silica nanoparticles | Immunomodulatory drug | Antsiferova et al., 2013[186] |
PLGA polymeric nanoparticles | Antibody | Liu et al., 2017[103] | |
Natural product-based therapy | Silicate nanocomposite (VB8) | Copaiba oleoresin | de Almeida Borges et al., 2016[198] Henriques da Silva et al., 2015[200] |
PLGA polymeric nanoparticles | de Almeida Borges et al., 2018[199] | ||
Local therapy | PEG&PCL nanofibers | Curcumin | Boroumand et al., 2019[102] |
Biodistribution in patients | Lipid core nanoparticles | N/A | Pogdaec et al., 2019[70] |